PRJSC “Indar”

Category: Status: being prepared

The company with a complete technological cycle of production of genetically engineered insulins from substance to finished dosage forms. Production by own technology of the whole spectrum of human insulin preparations recombinant. The capacity of Kyiv’s Indar insulin plant allows the production of 13-15 million bottles of the drug per year. The only producer of animal insulin in Ukraine.

Description

Business activity: complete technological cycle of production of genetically engineered insulins from substance to finished dosage forms. Production by own technology of the whole spectrum of human insulin preparations recombinant.

Facilities: the capacity of Kyiv’s Indar insulin plant allows the production of 13-15 million bottles of the drug per year. The only producer of animal insulin in Ukraine.

Average number of employees: 300

Land plot: no data

Legal obligations: no data

Additional information: Main markets: Ukraine, Moldova, Kazakhstan, CIS, Brazil and others.

Share proposed for privatization: 70,7016%

Starting price: ТВС

Investment advisor: not selected

Additional information

Part Capital 70.7016
Asset address 02099 м. Київ, вул. Зрошувальна, 5
Region Kyiv
Type of activity according to NACE 21.20 - Виробництво фармацевтичних препаратів і матеріалів;
46.46 Оптова торгівля фармацевтичними товарами
Type of object of Large privatization пакет акцій
Responsible for the preparation of the object ФДМУ
The act by which the object is included in the List of privatization objects Розпорядження КМУ від 16.01.2019 № 36-р
Order of the SPFU RV on the decision on privatization від 08.06.2018 № 774
Governing body МОЗ
EDRPOU code 00012925
Registration number 21680915

Be the first to question “ PRJSC “Indar” ”